To JRMKE:
Now the last quarterly burn was a whopping 26.9 (27) million dollars. And has increased again as I predicted.
160 million dollars left, so they have enough to last a total of 1 year and 2 quarters, meaning at their burn which will probably still go up a couple million, probably about 1 year to go before new massive dilution.
In the meantime clinical advances are slow and any product still many many years away. Even a partner will usually only look to get in after Phase II results so not likely for the foreseeable future. It boggles the mind how buzzwords are keeping this company's market cap where it is.
How is your reading up on cash-burns going now?
News 
Market Data 
Discover 
